Skip to main content
. Author manuscript; available in PMC: 2015 Aug 10.
Published in final edited form as: Curr Top Med Chem. 2014;14(11):1348–1355. doi: 10.2174/1568026614666140506120647

Figure 2.

Figure 2

A, Absorbance spectra of the ferric ligand-free and ritonavir-bound CYP3A4 (black and red, respectively) and its ferrous ritonavir-bound form (blue). Absorbance maxima for each species are indicated. B, Atypical (V-shaped) dependence of the rate constant for the ritonavir binding reaction on ligand concentration. C, Active site of ritonavir-bound CYP3A4.